These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24220207)

  • 1. PharmGKB summary: mycophenolic acid pathway.
    Lamba V; Sangkuhl K; Sanghavi K; Fish A; Altman RB; Klein TE
    Pharmacogenet Genomics; 2014 Jan; 24(1):73-9. PubMed ID: 24220207
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring of mycophenolic acid in clinical transplantation.
    Shaw LM; Pawinski T; Korecka M; Nawrocki A
    Ther Drug Monit; 2002 Feb; 24(1):68-73. PubMed ID: 11805725
    [No Abstract]   [Full Text] [Related]  

  • 3. PharmGKB summary: cyclosporine and tacrolimus pathways.
    Barbarino JM; Staatz CE; Venkataramanan R; Klein TE; Altman RB
    Pharmacogenet Genomics; 2013 Oct; 23(10):563-85. PubMed ID: 23922006
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil: how to further improve using an already successful drug?
    van Gelder T
    Am J Transplant; 2005 Feb; 5(2):199-200. PubMed ID: 15643976
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenetics of mycophenolate mofetil: a promising different approach to tailoring immunosuppression?
    Betonico GN; Abudd-Filho M; Goloni-Bertollo EM; Pavarino-Bertelli E
    J Nephrol; 2008; 21(4):503-9. PubMed ID: 18651539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil.
    Lipsky JJ
    Lancet; 1996 Nov; 348(9038):1357-9. PubMed ID: 8918281
    [No Abstract]   [Full Text] [Related]  

  • 7. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion.
    Shaw LM; Holt DW; Oellerich M; Meiser B; van Gelder T
    Ther Drug Monit; 2001 Aug; 23(4):305-15. PubMed ID: 11477311
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic drug monitoring for mycophenolic acid is value for (little) money.
    van Gelder T
    Clin Pharmacol Ther; 2011 Aug; 90(2):203-4. PubMed ID: 21772294
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA
    Curr Opin Cardiol; 1998 Mar; 13(2):117-21. PubMed ID: 9593551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we monitor mycophenolic acid plasma levels in pediatric renal transplantation?
    Tönshoff B
    Pediatr Transplant; 2015 Nov; 19(7):665-6. PubMed ID: 26435035
    [No Abstract]   [Full Text] [Related]  

  • 11. Scientific principles for mycophenolic acid therapeutic drug monitoring.
    Shaw LM; Korecka M; Aradhye S; Grossman R; Barker C; Naji A; Brayman KL
    Transplant Proc; 1998 Aug; 30(5):2234-6. PubMed ID: 9723454
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
    Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
    [No Abstract]   [Full Text] [Related]  

  • 13. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.
    Nicholls AJ
    Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430
    [No Abstract]   [Full Text] [Related]  

  • 14. New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation.
    de Jonge H; Naesens M; Kuypers DR
    Ther Drug Monit; 2009 Aug; 31(4):416-35. PubMed ID: 19536049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic monitoring of mycophenolic acid. A consensus panel report.
    Shaw LM; Nicholls A; Hale M; Armstrong VW; Oellerich M; Yatscoff R; Morris RE; Holt DW; Venkataramanan R; Haley J; Halloran P; Ettenger R; Keown P; Morris RG
    Clin Biochem; 1998 Jul; 31(5):317-22. PubMed ID: 9721428
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil for transplantation: new drug, old problems?
    Gray DW
    Lancet; 1995 Aug; 346(8972):390. PubMed ID: 7623565
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid.
    Shaw LM; Korecka M; van Breeman R; Nowak I; Brayman KL
    Clin Biochem; 1998 Jul; 31(5):323-8. PubMed ID: 9721429
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
    Thervet E; Anglicheau D; Legendre C; Beaune P
    Ther Drug Monit; 2008 Apr; 30(2):143-50. PubMed ID: 18367973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.
    Klupp J; van Gelder T; Dambrin C; Regieli J; Boeke K; Billingham ME; Morris RE
    Transplant Proc; 2001 May; 33(3):2170-1. PubMed ID: 11377490
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation.
    Hale MD; Nicholls AJ; Bullingham RE; Hené R; Hoitsma A; Squifflet JP; Weimar W; Vanrenterghem Y; Van de Woude FJ; Verpooten GA
    Clin Pharmacol Ther; 1998 Dec; 64(6):672-83. PubMed ID: 9871432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.